Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glaucoma, Neovascular × Ranibizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 6 Retinal Diseases 2 Melanoma 2 Retinoblastoma 1 Neurofibromatosis 1 1 Neurofibroma 1 Macular Edema 1 Macular Degeneration 1 Glaucoma, Neovascular 1 Conjunctival Neoplasms 1 Choroid Diseases 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00765921 2016-12-02

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

Massachusetts Eye and Ear Infirmary

Phase 1 Completed

Uveal Melanoma, Macular Edema, Glaucoma, Neovascular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡